NovoCure (NVCR) EBIT (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.91% |
| Dec 31, 2025 | -12.14% |
| Sep 30, 2025 | 8.86% |
| Jun 30, 2025 | -4.37% |
| Mar 31, 2025 | 40.19% |
| Dec 31, 2024 | -97.26% |
| Sep 30, 2024 | 4.43% |
| Jun 30, 2024 | 19.12% |
| Mar 31, 2024 | 19.72% |
| Dec 31, 2023 | 11.21% |
| Sep 30, 2023 | 7.05% |
| Jun 30, 2023 | -4.00% |
| Mar 31, 2023 | -40.19% |
| Dec 31, 2022 | -74.63% |
| Sep 30, 2022 | -16.49% |
| Jun 30, 2022 | -2,521.34% |
| Mar 31, 2022 | 96.56% |
| Dec 31, 2021 | -173.60% |
| Sep 30, 2021 | 30.44% |
| Jun 30, 2021 | -13,871.59% |
| Mar 31, 2021 | -100.73% |
| Dec 31, 2020 | -19.50% |
| Sep 30, 2020 | 125.28% |
| Jun 30, 2020 | 297.22% |
| Mar 31, 2020 | -2,309.80% |
| Dec 31, 2019 | -96.03% |
| Sep 30, 2019 | 222.32% |
| Jun 30, 2019 | 119.55% |
| Mar 31, 2019 | 29.39% |
| Dec 31, 2018 | -65.15% |
| Sep 30, 2018 | 25.96% |
| Jun 30, 2018 | 44.11% |
| Mar 31, 2018 | -181.34% |
| Dec 31, 2017 | 23.87% |
| Sep 30, 2017 | 61.89% |
| Jun 30, 2017 | -16.13% |
| Mar 31, 2017 | 25.19% |
| Dec 31, 2016 | 36.75% |
| Sep 30, 2016 | 24.09% |
| Jun 30, 2016 | -16.59% |
| Mar 31, 2016 | -4.35% |
| Dec 31, 2015 | -26.27% |
| Sep 30, 2015 | 10.91% |
| Jun 30, 2015 | -23.97% |
| Mar 31, 2015 | 4.62% |
| Dec 31, 2014 | -28.51% |